Citadel Advisors
APXH

Citadel Advisors’s APEX HealthCare ETF APXH Stock Holding History

Citadel Advisors’s Portfolio APXH Stock Details APXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-347,275
Closed -$2.73M – 15781
2022
Q3 		$2.73M Buy
+347,275
New +$2.96M ﹤0.01% 4993

Other funds holding APXH

FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PWMG
Provence Wealth Management Group Irvine, California $186M AUM 38.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors's APXH Position: Q4 2022 in Review

Citadel Advisors sold out of APEX HealthCare ETF (APXH) in Q4 2022, closing a stake of 347,275 shares — an estimated $2.73M sold.

Citadel Advisors first reported a position in APXH in Q3 2022 and held it in 1 quarter. The position peaked at $2.73M in Q3 2022. 6 funds tracked by Wall St. Rank hold APXH as of Q4 2022.

  • Citadel Advisors reported no remaining APEX HealthCare ETF position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 347,275 APEX HealthCare ETF shares in Q4 2022, an estimated $2.73M.
  • Citadel Advisors first reported a position in APEX HealthCare ETF in Q3 2022 and held it in 1 quarter.
  • Citadel Advisors's APEX HealthCare ETF position peaked at $2.73M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held APEX HealthCare ETF as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.